LifeSouth Community Blood Centers, Inc. FDA Inspection Record
LifeSouth Community Blood Centers, Inc. is an FDA-inspected facility (FEI 3006497349) located in Mobile, AL, US. RegDataLab tracks 7 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Apr 7, 2025: No Action Indicated (NAI)
- Inspections on record
- 7 (2 VAI, 5 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 16, latest Aug 5, 2025
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Apr 7, 2025 | No Action Indicated (NAI) | No citations listed |
| Dec 15, 2022 | No Action Indicated (NAI) | No citations listed |
| Jun 25, 2018 | Voluntary Action Indicated (VAI) | Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b)) |
| Jan 8, 2016 | No Action Indicated (NAI) | No citations listed |
| Aug 21, 2014 | Voluntary Action Indicated (VAI) | Equipment calibration frequency (21 CFR 606.60(b)) Required records (21 CFR 606.160(b)) Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b)) |
| Jul 19, 2012 | No Action Indicated (NAI) | No citations listed |
| Jan 28, 2010 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Aug 5, 2025 | Class II | B-0125-2026 | Apheresis Platelets, Leukocytes Reduced, Irradiated Apheresis Platelets, Leukocytes Reduced, Irradiated, for which platelet yield did not meet specifications, were distributed. |
| Jul 29, 2025 | Class II | B-0123-2026 | Apheresis Platelets, Leukocytes Reduced Apheresis Platelets, Leukocytes Reduced, for which platelet yield did not meet specifications, were distributed. |
| Apr 2, 2025 | Class II | B-0137-2026 | Apheresis Platelets, Leukocytes Reduced Apheresis Platelets, Leukocytes Reduced, for which platelet yield did not meet specifications, were distributed. |
| Apr 2, 2025 | Class II | B-0141-2026 | Apheresis Red Blood Cells, Leukocytes Reduced Apheresis Red Blood Cells, Leukocytes Reduced, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell… |
| Mar 18, 2024 | Class II | B-0362-2024 | Apheresis Red Blood Cells, Leukocytes Reduced Leukoreduced Apheresis Red Blood Cells, which were not tested for hematocrit, were distributed. |
| Jul 11, 2023 | Class II | B-0631-2023 | Apheresis Platelets, Leukocytes Reduced Plateletpheresis product, for which the quality control testing for pH did not meet specifications, was distributed. |
| Aug 27, 2022 | Class II | B-0201-2023 | Apheresis Platelets, Leukocytes Reduced Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed. |
| Aug 10, 2022 | Class II | B-0087-2023 | Apheresis Platelets, Leukocytes Reduced Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed. |
| Aug 4, 2022 | Class II | B-0188-2023 | Apheresis Platelets, Leukocytes Reduced Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed. |
| Jul 8, 2021 | Class II | B-0532-2021 | Red Blood Cells, Leukocytes Reduced Red Blood Cell product, collected from a donor who had previously tested reactive for Hepatitis C (HCV), was distributed. |
FDA record score
34 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
18 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall B-0125-2026, this FEI as the recalling firm | Aug 5, 2025 | 4 x 1 | 4 |
| Class II recall B-0123-2026, this FEI as the recalling firm | Jul 29, 2025 | 4 x 1 | 4 |
| Class II recall B-0137-2026, this FEI as the recalling firm | Apr 2, 2025 | 4 x 1 | 4 |
| Class II recall B-0141-2026, this FEI as the recalling firm | Apr 2, 2025 | 4 x 1 | 4 |
| Class II recall B-0362-2024, this FEI as the recalling firm | Mar 18, 2024 | 4 x 0.6 | 2.4 |
| Class II recall B-0631-2023, this FEI as the recalling firm | Jul 11, 2023 | 4 x 0.6 | 2.4 |
| Class II recall B-0201-2023, this FEI as the recalling firm | Aug 27, 2022 | 4 x 0.6 | 2.4 |
| Class II recall B-0087-2023, this FEI as the recalling firm | Aug 10, 2022 | 4 x 0.6 | 2.4 |
| Class II recall B-0188-2023, this FEI as the recalling firm | Aug 4, 2022 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Jun 25, 2018 | 6 x 0.25 | 1.5 |
| Class II recall B-0532-2021, this FEI as the recalling firm | Jul 8, 2021 | 4 x 0.25 | 1 |
| Class II recall B-0192-2021, this FEI as the recalling firm | Nov 5, 2020 | 4 x 0.25 | 1 |
| Class II recall B-0050-2021, this FEI as the recalling firm | Oct 27, 2020 | 4 x 0.25 | 1 |
| Class II recall B-0377-2017, this FEI as the recalling firm | Dec 2, 2016 | 4 x 0.25 | 1 |
| Class II recall B-0251-16, this FEI as the recalling firm | Jan 23, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 21, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall B-2125-13, this FEI as the recalling firm | Mar 26, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1272-13, this FEI as the recalling firm | Dec 11, 2012 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 14, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 14, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 2, 2026 | Newest record Oct 22, 2026 | Current |
Reviewing LifeSouth Community Blood Centers, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check LifeSouth Community Blood Centers, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- LifeSouth Community Blood Centers, Inc.
- Location
- Mobile, AL (US)
- Source
- inspections